Role of Immunohistochemistry in Staging Diffuse Large B-cell Lymphoma (DLBCL)

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Histochemistry and Cytochemistry

• Publication date

  2008-06-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1369/jhc.2008.951087PMID 18574254PMCID PMC2544620
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B‐cell lymphoma (DLBCL) – a new perspective

  2008cited by this paper
• Haematopathology practice: the commonest problems encountered in a consultation practice

  2007cited by this paper
• Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index.

  2007cited by this paper
• Prognostic biomarkers in diffuse large B-cell lymphoma.

  2006cited by this paper
• The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement

  2006influential reference
• Flow Cytometric Immunophenotyping Analysis of Patterns of Antigen Expression in Non‐Hodgkin's B Cell Lymphoma in Samples Obtained from Different Anatomic Sites

  2004cited by this paper
• Clinical utility of bone marrow flow cytometry in B‐cell non‐Hodgkin lymphomas (B‐NHL)

  2004cited by this paper
• Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.

  2004cited by this paper
• Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma.

  2003cited by this paper
• Immunophenotypic variability of B-cell non-Hodgkin lymphoma: a retrospective study of cases analyzed by flow cytometry.

  2002cited by this paper
• Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas.

  2001cited by this paper
• Bone marrow trephine biopsy.

  2001cited by this paper
• Fixation and Epitope Retrieval in Diagnostic Immunohistochemistry: A Concise Review with Practical Considerations

  2000cited by this paper
• Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma.

  1999cited by this paper
• The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.

  1999cited by this paper
• Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

  1999cited by this paper
• World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

  1999cited by this paper
• Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5− with CD10+ groups may constitute clinically relevant subtypes

  1999cited by this paper
• De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation.

  1998cited by this paper
• Bone marrow trephine biopsy in infants

  1997cited by this paper
• Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma.

  1995cited by this paper
• Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance.

  1995cited by this paper
• Paraffin-resistant antigens detectable by antibodies L26 and polyclonal CD3 predict the B- or T-cell lineage of 95% of diffuse aggressive non-Hodgkin's lymphomas.

  1994cited by this paper
• A predictive model for aggressive non-Hodgkin's lymphoma.

  1993cited by this paper
• Bone marrow examination in non‐Hodgkin's lymphoma: comparison of the diagnostic value of marrow aspirations and trephine biopsy

  1991cited by this paper
• Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.

  1990cited by this paper
• Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma.

  1990cited by this paper

• Relapse of Diffuse Large B‐Cell Lymphoma as Painless Masses in the Abdominal Wall Muscles: A Rare Case Report

  2025cites this paper
• An immunohistochemical study of diffuse large B-cell lymphoma with molecular subtyping based on Hans algorithm.

  2023cites this paper
• Challenges Encountered and Pattern-Based Analysis of Bone Marrow Biopsy in Lymphomas: An Institutional Experience

  2022cites this paper
• Diffuse large B-cell lymphoma: morphologic and immunohistochemical analysis of bone marrow for staging, with emphasis on lymphoid aggregates.

  2022cites this paper
• Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study

  2018cites this paper
• Hepatitis C Virus Associations with Non Hodgkin's Lymphoma: Insights on Inflammation/Angiogenesis and CD Markers.

  2016cites this paper
• [Diagnostic value of three evaluation methods of ¹⁸F-FDG PET/CT in detecting bone marrow infiltration in patients with newly diagnosed diffuse large B-cell lymphoma].

  2015cites this paper
• 18F-FDG PET/CT三种评价方法在初治弥漫大B细胞淋巴瘤患者骨髓受累中的诊断价值

  2015cites this paper
• Immunohistochemical and clinicopathological study of non-Hodgkin's lymphoma in Erbil, Kurdistan

  2014cites this paper
• Linfoma B difuso de células grandes: factores pronósticos en la era del rituximab

  2013cites this paper
• Value of 18F-FDG PET versus iliac biopsy in the initial evaluation of bone marrow infiltration in the case of Hodgkin’s disease: a meta-analysis

  2013cites this paper
• Hubungan antara Imunoekspresi Bcl-2 dan Caspase-3 dengan Respon Kemoterapi CHOP pada Limfoma Malignum Non-Hodgkin Tipe Sel B CD20 Positif

  2013cites this paper
• Association of Morphology and Immunophenotype in Diffuse Large B-Cell Lymphomas with Bone Marrow Infiltration in a Sample Mexican Population

  2012cites this paper
• Precision of histological bone marrow staging in follicular lymphoma and diffuse large B-cell lymphoma.

  2012cites this paper
• Chapter 13 – Lymphomas of the Bone Marrow

  2011cites this paper
• Staging bone marrow in diffuse large B‐cell lymphoma: the role of ancillary investigations

  2009influential citation
• Bone marrow involvement by hodgkin and non-hodgkin lymphomas.

  2009cites this paper
• Bone marrow biopsy in non-Hodgkin lymphoma: a morphological study.

  2009cites this paper
• New developments in the pathology of malignant lymphoma: a review of the literature published from May to July 2008

  2008cites this paper